ResMed
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,224,509 | $1,223,195 | $1,196,980 | $1,162,801 |
Gross Profit | 717,219 | 704,265 | 681,577 | 646,934 |
EBITDA | 442,709 | 422,036 | 429,226 | 392,692 |
EBIT | 388,999 | 367,282 | 374,584 | 339,322 |
Net Income | 311,355 | 292,236 | 300,492 | 208,800 |
Net Change In Cash | 1,224,509 | 1,223,195 | 1,196,980 | 1,162,801 |
Free Cash Flow | 305,931 | 413,791 | 378,922 | 248,274 |
Cash | 426,361 | 238,361 | 237,910 | 210,247 |
Basic Shares | 147,599 | 147,533 | 147,450 | 147,545 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
Revenue | $4,685,297 | $4,222,993 | $3,578,127 | $3,196,825 |
Gross Profit | 2,655,303 | 2,355,662 | 2,024,311 | 1,839,100 |
EBITDA | 1,533,543 | 1,358,801 | 1,176,636 | 1,099,169 |
EBIT | 1,317,334 | 1,162,279 | 982,795 | 907,651 |
Net Income | 1,020,951 | 897,556 | 779,437 | 474,505 |
Net Change In Cash | 4,685,297 | 4,222,993 | 3,578,127 | 3,196,825 |
Free Cash Flow | 1,286,404 | 559,299 | 195,111 | 619,892 |
Cash | 238,361 | 227,891 | 273,710 | 295,278 |
Basic Shares | 147,550 | 147,455 | 147,043 | 146,451 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $2.20 |
2024-06-30 | $2.08 |
2024-03-31 | $2.13 |
2023-12-31 | $1.88 |
